Cargando…
Nerve Ultrasound of Peripheral Nerves in Patients Treated with Immune Checkpoint Inhibitors
Background and Objectives: Immune checkpoint inhibitors (ICIs) have enriched tumor therapy, improving overall survival. Immunotherapy adverse events (irAEs) occur in up to 50% of patients and also affect the peripheral nervous system. The exact pathomechanism is unclear; however, an autoimmune proce...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302462/ https://www.ncbi.nlm.nih.gov/pubmed/37374207 http://dx.doi.org/10.3390/medicina59061003 |
_version_ | 1785065050414776320 |
---|---|
author | Kneer, Katharina Stahl, Jan-Hendrik Kronlage, Cornelius Bombach, Paula Renovanz, Mirjam Winter, Natalie Grimm, Alexander |
author_facet | Kneer, Katharina Stahl, Jan-Hendrik Kronlage, Cornelius Bombach, Paula Renovanz, Mirjam Winter, Natalie Grimm, Alexander |
author_sort | Kneer, Katharina |
collection | PubMed |
description | Background and Objectives: Immune checkpoint inhibitors (ICIs) have enriched tumor therapy, improving overall survival. Immunotherapy adverse events (irAEs) occur in up to 50% of patients and also affect the peripheral nervous system. The exact pathomechanism is unclear; however, an autoimmune process is implicated. Thus, the clinical evaluation of irAEs in the peripheral nervous system is still demanding. We retrospectively analyzed nerve ultrasound (NU) data of polyneuropathies (PNPs) secondary to checkpoint inhibitors. Materials and Methods: NU data of patients with PNP symptoms secondary to ICI therapy were retrospectively analyzed using the Ultrasound Pattern Sum Score (UPSS) as a quantitative marker. Our findings were compared with a propensity score match analysis (1:1 ratio) to NU findings in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) and chemotherapy-associated PNP patients. Results: In total, 10 patients were included (4 female, mean age 66 ± 10.5, IQR 60–77), where NU was performed in 80%. The UPSS obtained ranged from 0 to 5 (mean 2 ± 1.6, IQR 1–2.5). The morphological changes seen in the NUs resembled sonographic changes seen in chemotherapy-associated PNP (n = 10, mean UPSS 1 ± 1, IQR 0–2) with little to no nerve swelling. In contrast, CIDP patients had a significantly higher UPSS (n = 10, mean UPSS 11 ± 4, IQR 8–13, p < 0.0001). Conclusions: Although an autoimmune process is hypothesized to cause peripheral neurological irAEs, NU showed no increased swelling as seen in CIDP. The nerve swelling observed was mild and comparable to ultrasound findings seen in chemotherapy-associated PNP. |
format | Online Article Text |
id | pubmed-10302462 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103024622023-06-29 Nerve Ultrasound of Peripheral Nerves in Patients Treated with Immune Checkpoint Inhibitors Kneer, Katharina Stahl, Jan-Hendrik Kronlage, Cornelius Bombach, Paula Renovanz, Mirjam Winter, Natalie Grimm, Alexander Medicina (Kaunas) Article Background and Objectives: Immune checkpoint inhibitors (ICIs) have enriched tumor therapy, improving overall survival. Immunotherapy adverse events (irAEs) occur in up to 50% of patients and also affect the peripheral nervous system. The exact pathomechanism is unclear; however, an autoimmune process is implicated. Thus, the clinical evaluation of irAEs in the peripheral nervous system is still demanding. We retrospectively analyzed nerve ultrasound (NU) data of polyneuropathies (PNPs) secondary to checkpoint inhibitors. Materials and Methods: NU data of patients with PNP symptoms secondary to ICI therapy were retrospectively analyzed using the Ultrasound Pattern Sum Score (UPSS) as a quantitative marker. Our findings were compared with a propensity score match analysis (1:1 ratio) to NU findings in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) and chemotherapy-associated PNP patients. Results: In total, 10 patients were included (4 female, mean age 66 ± 10.5, IQR 60–77), where NU was performed in 80%. The UPSS obtained ranged from 0 to 5 (mean 2 ± 1.6, IQR 1–2.5). The morphological changes seen in the NUs resembled sonographic changes seen in chemotherapy-associated PNP (n = 10, mean UPSS 1 ± 1, IQR 0–2) with little to no nerve swelling. In contrast, CIDP patients had a significantly higher UPSS (n = 10, mean UPSS 11 ± 4, IQR 8–13, p < 0.0001). Conclusions: Although an autoimmune process is hypothesized to cause peripheral neurological irAEs, NU showed no increased swelling as seen in CIDP. The nerve swelling observed was mild and comparable to ultrasound findings seen in chemotherapy-associated PNP. MDPI 2023-05-23 /pmc/articles/PMC10302462/ /pubmed/37374207 http://dx.doi.org/10.3390/medicina59061003 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kneer, Katharina Stahl, Jan-Hendrik Kronlage, Cornelius Bombach, Paula Renovanz, Mirjam Winter, Natalie Grimm, Alexander Nerve Ultrasound of Peripheral Nerves in Patients Treated with Immune Checkpoint Inhibitors |
title | Nerve Ultrasound of Peripheral Nerves in Patients Treated with Immune Checkpoint Inhibitors |
title_full | Nerve Ultrasound of Peripheral Nerves in Patients Treated with Immune Checkpoint Inhibitors |
title_fullStr | Nerve Ultrasound of Peripheral Nerves in Patients Treated with Immune Checkpoint Inhibitors |
title_full_unstemmed | Nerve Ultrasound of Peripheral Nerves in Patients Treated with Immune Checkpoint Inhibitors |
title_short | Nerve Ultrasound of Peripheral Nerves in Patients Treated with Immune Checkpoint Inhibitors |
title_sort | nerve ultrasound of peripheral nerves in patients treated with immune checkpoint inhibitors |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302462/ https://www.ncbi.nlm.nih.gov/pubmed/37374207 http://dx.doi.org/10.3390/medicina59061003 |
work_keys_str_mv | AT kneerkatharina nerveultrasoundofperipheralnervesinpatientstreatedwithimmunecheckpointinhibitors AT stahljanhendrik nerveultrasoundofperipheralnervesinpatientstreatedwithimmunecheckpointinhibitors AT kronlagecornelius nerveultrasoundofperipheralnervesinpatientstreatedwithimmunecheckpointinhibitors AT bombachpaula nerveultrasoundofperipheralnervesinpatientstreatedwithimmunecheckpointinhibitors AT renovanzmirjam nerveultrasoundofperipheralnervesinpatientstreatedwithimmunecheckpointinhibitors AT winternatalie nerveultrasoundofperipheralnervesinpatientstreatedwithimmunecheckpointinhibitors AT grimmalexander nerveultrasoundofperipheralnervesinpatientstreatedwithimmunecheckpointinhibitors |